Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › VA › SOUTH HILL › COMMUNITY MEMORIAL HOSPITAL

COMMUNITY MEMORIAL HOSPITAL

NPI: 1336103738 · SOUTH HILL, VA 23970 · Rural Acute Care Hospital · NPI assigned 04/13/2006

$35.67M
Total Medicaid Paid
744,624
Total Claims
537,992
Beneficiaries
314
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHARLAN, ELIZABETH (REVENUE CYCLE DIRECTOR)
NPI Enumeration Date04/13/2006

Related Entities

Other providers sharing the same authorized official: HARLAN, ELIZABETH

ProviderCityStateTotal Paid
VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM AUTHORITY RICHMOND VA $658.49M
VCU HEALTH TAPPAHANNOCK HOSPITAL TAPPAHANNOCK VA $20.60M
VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM AUTHORITY RICHMOND VA $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 68,560 $1.69M
2019 102,749 $3.41M
2020 94,678 $4.17M
2021 96,560 $4.80M
2022 129,385 $6.16M
2023 142,333 $8.93M
2024 110,359 $6.51M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 23,376 20,474 $5.53M
99284 Emergency department visit for the evaluation and management, high severity 20,983 17,458 $4.68M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 16,035 13,175 $3.50M
96361 Intravenous infusion, hydration; each additional hour 10,667 8,000 $3.28M
74177 Computed tomography, abdomen and pelvis; with contrast material 4,465 3,882 $1.40M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 26,752 6,257 $1.31M
70450 Computed tomography, head or brain; without contrast material 5,866 4,943 $1.21M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 6,198 1,569 $1.10M
99282 Emergency department visit for the evaluation and management, low to moderate severity 4,182 3,817 $893K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2,557 2,170 $864K
74176 Computed tomography, abdomen and pelvis; without contrast material 3,193 2,666 $809K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2,664 2,473 $714K
G0378 Hospital observation service, per hour 4,230 2,478 $697K
59025 Fetal non-stress test 2,348 1,346 $631K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2,315 1,613 $621K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 6,395 4,959 $582K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 3,102 2,628 $467K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,627 5,420 $441K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2,995 1,593 $402K
97530 Therapeutic activities, direct patient contact, each 15 minutes 7,196 3,444 $399K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 11,651 3,358 $382K
71275 Computed tomographic angiography, chest, with contrast material 765 677 $285K
97161 2,263 1,917 $269K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 288 253 $234K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 3,215 1,789 $228K
77067 Screening mammography, bilateral, including computer-aided detection 3,672 3,471 $201K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1,941 1,777 $188K
80053 Comprehensive metabolic panel 36,324 27,151 $184K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,872 3,500 $179K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 347 309 $168K
J9271 Injection, pembrolizumab, 1 mg 33 24 $165K
76830 Ultrasound, transvaginal 1,120 1,025 $153K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 499 282 $150K
59899 211 148 $147K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1,095 1,002 $127K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2,159 1,510 $115K
77063 Screening digital breast tomosynthesis, bilateral 2,725 2,582 $112K
97113 1,341 445 $110K
71260 Computed tomography, thorax, diagnostic; with contrast material 1,312 1,163 $105K
76705 Ultrasound, abdominal, real time with image documentation; limited 680 612 $96K
97035 1,933 567 $93K
71250 1,126 1,018 $93K
87632 657 629 $82K
76642 533 433 $76K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 4,253 3,681 $71K
71046 Radiologic examination, chest; 2 views 4,366 3,869 $71K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4,283 3,705 $67K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 106 86 $59K
72125 Computed tomography, cervical spine; without contrast material 1,118 1,003 $56K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 40,829 29,715 $54K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 510 416 $54K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,784 1,843 $54K
80048 Basic metabolic panel (calcium, ionized) 12,307 8,645 $52K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 61 49 $48K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 4,249 3,897 $45K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 142 134 $43K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1,590 466 $40K
84443 Thyroid stimulating hormone (TSH) 4,687 3,968 $39K
85027 9,988 7,341 $37K
97162 220 179 $36K
76801 471 403 $35K
93971 288 254 $35K
36415 Collection of venous blood by venipuncture 17,569 13,305 $34K
83880 3,438 2,842 $33K
70498 73 66 $33K
94726 402 363 $31K
94727 525 480 $29K
96367 818 596 $27K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1,738 1,517 $24K
93017 375 331 $24K
97165 323 272 $23K
87086 Culture, bacterial; quantitative colony count, urine 7,339 6,116 $23K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,224 1,724 $23K
84702 3,020 2,375 $22K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 2,306 2,151 $22K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 11,015 6,973 $22K
64483 17 13 $21K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 30 26 $20K
94729 464 423 $20K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 15,877 12,460 $20K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,095 997 $19K
43235 109 82 $19K
71045 Radiologic examination, chest; single view 11,026 8,974 $19K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 150 127 $19K
87040 2,139 1,645 $18K
88142 872 700 $18K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 14,466 11,379 $17K
83036 Hemoglobin; glycosylated (A1C) 3,111 2,755 $17K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 95 86 $15K
82948 11,748 3,385 $15K
80061 Lipid panel 2,964 2,660 $15K
94060 186 172 $15K
86780 1,331 1,205 $15K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 111 87 $14K
96523 226 162 $14K
84484 11,722 8,757 $14K
70486 174 163 $14K
87486 2,301 2,147 $13K
78815 Positron emission tomography (PET) for limited area imaging 14 12 $13K
90715 498 468 $13K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 288 269 $13K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 768 685 $13K
99215 Prolong outpt/office vis 120 87 $12K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 35 21 $12K
76536 81 78 $12K
87581 2,300 2,146 $12K
73030 878 737 $12K
83735 13,332 8,605 $11K
86803 622 516 $11K
87631 859 744 $10K
97116 408 184 $10K
86900 3,213 2,611 $10K
87340 1,697 1,448 $10K
36430 14 12 $10K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 79 64 $9K
81025 9,886 8,179 $9K
85379 1,956 1,698 $9K
71271 74 67 $9K
81001 20,817 16,776 $9K
92523 31 30 $8K
J7030 Infusion, normal saline solution , 1000 cc 15,706 11,082 $8K
74018 444 390 $8K
86850 2,885 2,367 $8K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 313 254 $8K
81003 5,217 4,125 $8K
36591 1,559 784 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 476 371 $7K
84145 502 408 $7K
73630 806 700 $7K
12001 29 25 $7K
87634 239 226 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,293 1,090 $7K
93799 1,582 655 $7K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 228 205 $6K
81329 180 146 $6K
87653 145 130 $6K
87081 3,400 3,075 $6K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 114 108 $6K
72100 249 224 $6K
83605 4,820 3,823 $6K
85610 5,430 3,789 $6K
80320 1,933 1,644 $5K
96375 Therapeutic injection; each additional sequential IV push 11,997 8,694 $5K
J1610 Injection, glucagon hydrochloride, per 1 mg 197 129 $5K
86140 771 695 $5K
86901 3,212 2,611 $5K
82607 567 509 $5K
73610 692 622 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg 10,081 7,460 $5K
82728 496 440 $5K
77066 Tomosynthesis, mammo 102 97 $5K
80143 672 588 $4K
0064U 337 284 $4K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 20 14 $4K
70551 Magnetic resonance imaging, brain; without contrast material 15 13 $4K
76775 41 38 $4K
94618 27 24 $4K
J7120 Ringers lactate infusion, up to 1000 cc 5,346 3,714 $4K
80329 261 202 $4K
G0475 Hiv antigen/antibody, combination assay, screening 363 344 $4K
73130 375 325 $4K
P9016 Red blood cells, leukocytes reduced, each unit 15 12 $4K
85652 1,035 908 $3K
73502 245 224 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,352 2,998 $3K
82950 401 367 $3K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 798 425 $3K
83021 367 305 $3K
86787 305 250 $3K
96376 4,534 2,414 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg 9,243 7,415 $3K
80076 541 359 $3K
77080 46 38 $3K
84153 253 229 $3K
87077 2,538 2,134 $2K
84100 3,442 1,909 $2K
36600 420 328 $2K
96415 93 39 $2K
80179 631 555 $2K
83690 7,288 5,975 $2K
83540 514 454 $2K
82248 2,053 1,446 $2K
86762 314 266 $2K
84466 321 285 $2K
87205 631 522 $2K
87102 124 117 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 3,299 2,485 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg 5,200 3,373 $2K
85730 3,721 2,960 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 57 52 $2K
73564 357 305 $2K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 3,174 2,259 $2K
87184 1,864 1,563 $2K
94010 62 56 $2K
74022 415 354 $2K
82105 111 95 $2K
82746 188 172 $1K
A9270 Non-covered item or service 629 471 $1K
82565 979 869 $1K
J3010 Injection, fentanyl citrate, 0.1 mg 3,874 2,733 $1K
84550 475 358 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 2,014 1,405 $1K
84156 286 222 $1K
73562 83 68 $1K
82550 819 644 $950.77
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 629 560 $917.71
70496 47 42 $892.63
82077 1,022 874 $783.83
97535 Self-care/home management training, each 15 minutes 61 39 $763.08
82805 1,240 1,003 $756.10
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 362 292 $706.52
82150 372 310 $684.35
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 12 12 $649.02
87088 649 527 $622.89
73110 114 97 $571.35
86336 34 29 $544.63
76000 153 133 $530.40
73560 29 26 $520.40
84132 814 658 $518.12
J1650 Injection, enoxaparin sodium, 10 mg 1,271 466 $515.29
J1644 Injection, heparin sodium, per 1000 units 2,965 1,031 $510.71
87210 657 568 $502.58
96402 13 12 $498.15
J0696 Injection, ceftriaxone sodium, per 250 mg 3,627 2,681 $496.41
J3490 Unclassified drugs 6,210 3,477 $473.69
77062 14 12 $471.72
86038 29 28 $462.07
J7050 Infusion, normal saline solution, 250 cc 6,079 2,607 $455.45
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,705 4,146 $435.62
G0103 Prostate cancer screening; prostate specific antigen test (psa) 42 35 $414.85
J2060 Injection, lorazepam, 2 mg 1,071 728 $393.38
J0171 Injection, adrenalin, epinephrine, 0.1 mg 327 263 $392.36
94761 1,392 1,113 $381.46
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,889 2,816 $379.16
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 761 477 $367.06
J2360 Injection, orphenadrine citrate, up to 60 mg 433 359 $355.25
86480 15 13 $345.94
87070 145 119 $345.30
82677 34 29 $341.20
J2270 Injection, morphine sulfate, up to 10 mg 3,384 2,257 $300.72
72040 13 13 $282.43
J1815 Injection, insulin, per 5 units 1,165 449 $271.51
84439 29 25 $255.11
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,752 1,373 $252.94
J3475 Injection, magnesium sulfate, per 500 mg 3,003 1,990 $252.91
86592 27 24 $233.99
J8540 Dexamethasone, oral, 0.25 mg 425 185 $172.20
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 979 771 $168.48
83615 85 62 $164.47
J1170 Injection, hydromorphone, up to 4 mg 2,361 1,406 $162.16
J0690 Injection, cefazolin sodium, 500 mg 2,159 1,377 $160.16
90686 22 18 $159.77
80050 General health panel 25 23 $153.93
87220 351 294 $148.34
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 1,077 803 $145.44
87147 141 135 $134.28
88342 19 13 $121.82
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 854 340 $117.19
83718 15 14 $113.21
J2175 Injection, meperidine hydrochloride, per 100 mg 1,201 787 $106.61
82553 108 73 $94.73
J2765 Injection, metoclopramide hcl, up to 10 mg 1,220 991 $91.78
86706 13 13 $72.48
C9399 Unclassified drugs or biologicals 19 12 $70.69
82465 15 14 $61.88
82784 18 12 $57.36
J2795 Injection, ropivacaine hydrochloride, 1 mg 285 238 $38.17
J0330 Injection, succinylcholine chloride, up to 20 mg 367 241 $37.79
88304 17 14 $33.80
J2550 Injection, promethazine hcl, up to 50 mg 236 189 $31.95
84478 15 14 $31.52
A9577 Injection, gadobenate dimeglumine (multihance), per ml 498 452 $29.28
86403 39 31 $28.19
J1030 Injection, methylprednisolone acetate, 40 mg 292 257 $21.36
J0780 Injection, prochlorperazine, up to 10 mg 488 386 $20.48
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 471 265 $19.59
J2704 Injection, propofol, 10 mg 3,646 2,744 $15.81
J3370 Injection, vancomycin hcl, 500 mg 76 49 $7.52
A4600 Sleeve for intermittent limb compression device, replacement only, each 194 130 $7.31
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 96 50 $7.27
J1940 Injection, furosemide, up to 20 mg 165 104 $6.60
C9113 Injection, pantoprazole sodium, per vial 458 262 $5.60
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 100 92 $1.92
J1630 Injection, haloperidol, up to 5 mg 20 12 $1.38
J7510 Prednisolone oral, per 5 mg 16 14 $1.38
90662 17 14 $0.97
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 325 68 $0.43
J1010 Injection, methylprednisolone acetate, 1 mg 28 28 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 112 94 $0.00
J2785 Injection, regadenoson, 0.1 mg 172 145 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 111 101 $0.00
A9585 Injection, gadobutrol, 0.1 ml 202 179 $0.00
J3535 Drug administered through a metered dose inhaler 89 53 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 75 62 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 17 14 $0.00
J3480 Injection, potassium chloride, per 2 meq 58 38 $0.00
94760 41 12 $0.00
C1889 Implantable/insertable device, not otherwise classified 12 12 $0.00
V2632 Posterior chamber intraocular lens 14 14 $0.00
82140 13 12 $0.00
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 569 460 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 176 125 $0.00
94664 29 25 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 114 87 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 209 155 $0.00
A4550 Surgical trays 114 90 $0.00
J1171 Injection, hydromorphone, 0.1 mg 49 36 $0.00
A9700 Supply of injectable contrast material for use in echocardiography, per study 16 12 $0.00
J7342 Instillation, ciprofloxacin otic suspension, 6 mg 34 25 $0.00
J1953 Injection, levetiracetam, 10 mg 14 12 $0.00
J1020 Injection, methylprednisolone acetate, 20 mg 14 14 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 27 24 $0.00
82247 36 12 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 19 13 $0.00